Form D · Biotechnology
BioLineRx Ltd.
Modi'in, L3 · CIK 0001498403
Offering snapshot reported Sep 9, 2026 · SEC filing
- Reported sold
- $3.75M Offering amount: $3.75M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 27, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 9, 2026 | Initial | $3,750,000 | No comparison | 1 | SEC filing |
| Jun 10, 2020 | Initial | $9,000,003 | No comparison | 6 | SEC filing |
| Jun 10, 2020 | Initial | $4,393,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $263K
- Finders' fees
- $0
- Form D file number
- 021-596873
The securities were issued in connection with an offering of (i) 480,696 American depositary shares (ADSs) and 868,225 pre-funded warrants to purchase ADSs in a registered direct offering, and (ii) unregistered warrants to purchase 2,023,382 ADSs.
Chardan is also entitled to 1.0% of the gross proceeds as management fee and $50,000 for accountable expenses.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Chardan Capital Markets LLC | 000120128 |
Source: Form D, filed Sep 9, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael J. Anghel | Director |
| Nurit Benjamini | Director |
| Bj Bormann | Director |
| Barbara Jean Bormann | Director |
| Gal Cohen | Director |
| Rami Dar | Director |
| Raphael Hofstein | Director |
| Avraham Molcho | Director |
| Sandra Panem | Director |
| Aharon Schwartz | Director |
| Philip A. Serlin | Executive |
| Ella Sorani | Executive |
| Abi Vainstein Haras | Executive |
| Shaoyu Yan | Director |
| Mali Zeevi | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2 Hama'ayan Street
Modi'in, L3, 7177871
Phone: 972-8-642-9100
Modi'in, L3, 7177871
Phone: 972-8-642-9100